Hemp-Based Topical Product for Cannabis Research

This trial examines how a hemp-based CBD (cannabidiol) lotion with a small amount of THC (a compound in cannabis that can cause a high) affects the body when used once or over time. The researchers aim to understand how the body absorbs and processes the lotion. Participants should be in good health and have prior experience with cannabis or CBD products, but must test negative for recent cannabis use. As a Phase 1 trial, this research focuses on understanding the treatment's effects in people, offering participants the opportunity to be among the first to receive this new treatment.

The trial does not clearly state if you must stop taking your current medications, but it mentions that if your medications might interfere with the study or your safety, you may not be eligible to participate. It's best to discuss your specific medications with the trial team.

Research has shown that creams and lotions with CBD and low THC levels are usually safe for most people. Studies indicate that CBD and similar compounds are unlikely to cause allergic reactions. Some reports even suggest they might help reduce skin allergies.

However, limited information exists about CBD's overall safety, so some risks might not be fully known yet. The FDA has expressed concerns about possible risks associated with using CBD. It's important to remember that while CBD is often sold as a supplement, it is not regulated like a medicine.

Researchers are excited about this treatment because it combines CBD with low levels of THC in a topical form, offering a new way to address conditions that might benefit from cannabis-based therapy. Unlike other treatments that are usually taken orally or smoked, this topical product allows for localized application, potentially reducing side effects and enhancing targeted relief. The inclusion of both CBD and THC leverages the therapeutic benefits of both cannabinoids, which could provide a broader range of symptom relief compared to CBD-only products. This unique combination and delivery method might offer more effective and safer options for individuals seeking cannabis-based treatment.

Research has shown that creams with cannabidiol (CBD) can benefit the skin by reducing swelling, itching, and pain. Studies have found that applying CBD directly to the skin may alleviate pain and swelling, particularly for conditions like arthritis. Some individuals report that CBD creams are more effective than common painkillers like ibuprofen for certain areas. While the evidence is promising, further research is needed to fully understand its effectiveness for other conditions. In this trial, participants will use a topical CBD product containing low levels of THC, which may also aid in reducing pain and swelling in specific areas.⁴⁶⁷⁸⁹